The University of Iowa Flow Cytometry Facility, established in 1979, was used by 22 departments across four colleges in 2013. Serving this diverse group of investigators requires instruments capable of accommodating a wide range of demands including multi-parameter high-speed cell sorting in a biologically safe manner. The Facility currently operates two cell sorters, a Becton Dickinson (BD) FACS Vantage/DiVa and a FACS Aria II/SORP, both of which are used heavily. There is no question that two cell sorters are necessary to fulfill the obligations of the NIH-funded investigators at this institution. Priorto acquiring the second cell sorter (the FACS Aria II) in 2010, the Facility had a minimum of a one month backlog for sorting experiments. The investigators made it clear that this long waiting period was interfering with their ability to complete their projects and put them at a competitive disadvantage. It is quite clear that this Facility needs two sorters for optimal service delivery. This proposal requests funds for a biologically contained BD FACS Aria SORP cell sorter to replace the BD FACS Vantage/DiVa. While the BD FACS Vantage/DiVa, installed in January 2002, has served as a work horse for a broad range of cell sorting experiments, it has become more difficult to support. BD discontinued sales of the FACS Vantage/DiVa family of instruments in 2007, ended DiVa software upgrades in 2008, and stopped offering service contracts after 2010. The three water-cooled main-frame lasers also require significant maintenance and expense to support. Third party suppliers do not offer Vantage/DiVa parts other than preventative maintenance kits. With parts and support difficult to obtain, there is increased likelihood that an unrecoverable failure that will render the instrument unusable. Moreover, while the Facility's newer BD FACS Aria II/SORP has an aerosol management system and is housed in a biosafety cabinet, the BD FACS Vantage/DiVa only utilizes an aerosol management system for biohazard protection. This has limited the types of samples that can be sorted and thus the projects that can be accommodated with the FACS DiVa. The University of Iowa Flow Cytometry Facility is the sole cell-sorting provider on campus. The only other publicly accessible cell sorter in the state of Iowa is housed at Iowa State University, approximately 130 miles away. The inevitable retirement of the BD FACS Vantage/DiVa will result in a significant adverse impact on the timely completion of the research of numerous investigators if not replaced with a new cell sorter.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10OD016199-01A1
Application #
8825322
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Horska, Alena
Project Start
2015-04-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52246
Li, Fengyin; Zeng, Zhouhao; Xing, Shaojun et al. (2018) Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun 9:5452
Xing, Shaojun; Shao, Peng; Li, Fengyin et al. (2018) Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. J Exp Med 215:2211-2226
Nalbant, Demet; Cancelas, José A; Mock, Donald M et al. (2018) In premature infants there is no decrease in 24-hour posttransfusion allogeneic red blood cell recovery after 42 days of storage. Transfusion 58:352-358
Martin, Matthew D; Shan, Qiang; Xue, Hai-Hui et al. (2017) Time and Antigen-Stimulation History Influence Memory CD8 T Cell Bystander Responses. Front Immunol 8:634
Li, Fengyin; He, Bing; Ma, Xiaoke et al. (2017) Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Cell Stem Cell 21:359-373.e5
Schmidt, Robert L; Mock, Donald M; Franco, Robert S et al. (2017) Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose. Transfusion 57:1488-1496
Barr, Jennifer Y; Wang, Xiaofang; Meyerholz, David K et al. (2017) CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome. Immunol Cell Biol 95:684-694
Gullicksrud, Jodi A; Li, Fengyin; Xing, Shaojun et al. (2017) Differential Requirements for Tcf1 Long Isoforms in CD8+ and CD4+ T Cell Responses to Acute Viral Infection. J Immunol 199:911-919
Shan, Qiang; Zeng, Zhouhao; Xing, Shaojun et al. (2017) The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage. Nat Immunol 18:931-939
Xing, Shaojun; Li, Fengyin; Zeng, Zhouhao et al. (2016) Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity. Nat Immunol 17:695-703